Keyphrases
Possible Mechanisms
100%
Metastatic Non-small Cell Lung Cancer
100%
Lorlatinib
100%
Minimal Change Disease
50%
Hypertriglyceridemia
50%
Lipid Profile
33%
Lung Cancer
16%
Malignancy
16%
Older Women
16%
Statin Therapy
16%
Dyslipidemia
16%
Management Outcome
16%
Renal Biopsy
16%
Crucial Aspect
16%
Lung Carcinoma
16%
Nephrotic-range Proteinuria
16%
Lung-other
16%
Ezetimibe
16%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Hyperlipidemia
100%
Lorlatinib
100%
Minimal Change Disease
33%
Lung Cancer
11%
Dyslipidemia
11%
Proteinuria
11%
Malignant Neoplasm
11%
Lung Adenocarcinoma
11%
Statin
11%
Renal Biopsy
11%
Ezetimibe
11%
Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Hyperlipidemia
100%
Lorlatinib
100%
Diseases
33%
Malignant Neoplasm
11%
Lung Cancer
11%
Statin (Protein)
11%
Lung Adenocarcinoma
11%
Ezetimibe
11%
Dyslipidemia
11%
Proteinuria
11%